Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Editorial

Page Path

HOME
ARTICLE CATEGORY
Editorial

Editorial

Do cirrhotic patients with a high MELD score benefit from TIPS?

Won Hyeok Choe

Clin Mol Hepatol. 2014;20(1):15-17. Published online March 26, 2014

DOI: https://doi.org/10.3350/cmh.2014.20.1.15

View: 5970 Download: 44 Web of Science: 4 Crossref: 3

Liver stiffness measurement: Is it a non-invasive substitution for HVPG?

Soung Won Jeong

Clin Mol Hepatol. 2013;19(4):367-369. Published online December 28, 2013

DOI: https://doi.org/10.3350/cmh.2013.19.4.367

View: 6143 Download: 49 Crossref: 4

Chasing after novel non-invasive markers to identify advanced fibrosis in NAFLD

Wonseok Kang, Seung Up Kim

Clin Mol Hepatol. 2013;19(3):255-257. Published online September 30, 2013

DOI: https://doi.org/10.3350/cmh.2013.19.3.255

View: 5674 Download: 48 Crossref: 2

Noninvasive markers: a double-edged sword that stratifies nonalcoholic steatohepatitis

Goh Eun Chung, Donghee Kim

Clin Mol Hepatol. 2013;19(2):116-119. Published online June 27, 2013

DOI: https://doi.org/10.3350/cmh.2013.19.2.116

View: 6766 Download: 91

Is peginterferon and ribavirin therapy effective in Korean patients with chronic hepatitis C?

Young Kul Jung, Ju Hyun Kim

Clin Mol Hepatol. 2013;19(1):26-28. Published online March 25, 2013

DOI: https://doi.org/10.3350/cmh.2013.19.1.26

View: 6211 Download: 47 Crossref: 4

Elevated serum bilirubin levels are inversely associated with nonalcoholic fatty liver disease

Byoung Kuk Jang

Clin Mol Hepatol. 2012;18(4):357-359. Published online December 21, 2012

DOI: https://doi.org/10.3350/cmh.2012.18.4.357

View: 6890 Download: 89 Crossref: 25

Impact of ribavirin dose reduction during treatment in chronic hepatitis C genotype 1 patients

Woo Jin Chung

Clin Mol Hepatol. 2012;18(3):268-271. Published online September 25, 2012

DOI: https://doi.org/10.3350/cmh.2012.18.3.268

View: 5614 Download: 45 Crossref: 1

Noninvasive diagnostic criteria for hepatocellular carcinoma

Han Chu Lee

Clin Mol Hepatol. 2012;18(2):174-177. Published online June 26, 2012

DOI: https://doi.org/10.3350/cmh.2012.18.2.174

View: 6314 Download: 53 Crossref: 3

The effect of alanine aminotransferase dynamics on predicting sustained virological response in chronic hepatitis C virus infection

Tae Yeob Kim

Clin Mol Hepatol. 2012;18(1):29-31. Published online March 22, 2012

DOI: https://doi.org/10.3350/kjhep.2012.18.1.29

View: 7081 Download: 34 Crossref: 4

A tool for communication with decision-makers: limitations and utilization of studies on cost of illness

Kun-Sei Lee

Clin Mol Hepatol. 2011;17(4):258-260. Published online December 26, 2011

DOI: https://doi.org/10.3350/kjhep.2011.17.4.258

View: 4941 Download: 35

Durability of antiviral therapy for chronic hepatitis C after achieving sustained virological response

Jeong Heo

Clin Mol Hepatol. 2011;17(3):180-182. Published online September 30, 2011

DOI: https://doi.org/10.3350/kjhep.2011.17.3.180

View: 6120 Download: 32

Percutaneous interventional procedures in an era of liver transplantation

Young Seok Kim

Clin Mol Hepatol. 2011;17(2):96-98. Published online June 23, 2011

DOI: https://doi.org/10.3350/kjhep.2011.17.2.96

View: 5675 Download: 35

Liver function tests as indicators of metabolic syndrome

Han Chu Lee

Clin Mol Hepatol. 2011;17(1):9-11. Published online March 21, 2011

DOI: https://doi.org/10.3350/kjhep.2011.17.1.9

View: 5377 Download: 49 Crossref: 4

Which treatment modality should we choose for advanced hepatocellular carcinoma?

Do Young Kim

Clin Mol Hepatol. 2010;16(4):353-354. Published online December 31, 2010

DOI: https://doi.org/10.3350/kjhep.2010.16.4.353

View: 5733 Download: 63

Hypoxia-inducible factor 1, hepatocellular carcinoma and angiogenesis

Jin-Wook Kim

Clin Mol Hepatol. 2010;16(3):278-279. Published online September 30, 2010

DOI: https://doi.org/10.3350/kjhep.2010.16.3.278

View: 5673 Download: 30 Crossref: 3

Clinical and
Molecular
Hepatology

Print ISSN: 2287-2728
Online ISSN: 2287-285X

Impact Factor

8.9
First decision

09 Days

Publication after acceptance

04 Days

*Last 12 months

MOST VIEWED (Last 6 months)

Viewed By 5424	Prognostic value of ultra-low-pass whole-genome sequencing of circulating tumor DNA in hepatocellular carcinoma under systemic treatment
Viewed By 5394	MAFLD: How is it different from NAFLD?
Viewed By 5288	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 3949	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Viewed By 3941	Global incidence and prevalence of nonalcoholic fatty liver disease

+more

MOST CITED (2022-2024)

Cited By 114	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 103	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 77	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 68	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach
Cited By 52	MAFLD: How is it different from NAFLD?

+more

Editorial Office
The Korean Association for the Study of the Liver
Room A1210, 53 Mapo-daero(MapoTrapalace, Dowha-dong), Mapo-gu, Seoul, 04158, Korea
TEL: +82-2-703-0051 FAX: +82-2-703-0071 E-mail: kasl@kams.or.kr

COUNTER

TODAY : 637

TOTAL : 1799568